KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,963,419 | +6.9% | 1,034,623 | -0.1% | 0.13% | +10.2% |
Q2 2023 | $9,323,415 | +16.9% | 1,035,935 | +2.1% | 0.12% | +5.4% |
Q1 2023 | $7,978,835 | +16.7% | 1,015,119 | +0.4% | 0.11% | +9.8% |
Q4 2022 | $6,836,868 | -11.0% | 1,011,371 | +91.0% | 0.10% | -12.1% |
Q3 2022 | $7,682,000 | +708.6% | 529,439 | +958.9% | 0.12% | +673.3% |
Q4 2020 | $950,000 | – | 50,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |